Chemours Co

NYSE: CC·Wilmington, Delaware·

Price
$12.48
Base IV
$14.17

Valuation snapshot

Below base case

At $12.48, the price sits between our bear case, which is below zero, and our base case ($14.17).

Values per share, from an .

No growth
…
Loading earnings power
Base case
$14.17
above today's price · range -$4.31–$43.73
Price vs base case
12% below
$12.48 against $14.17
Base casevalued by DCF
Price vs base
Priceclose 11‑16

Whisker on the base case runs bear -$4.31 to bull $43.73, cut off at zero. Values per share.

Price against each value

Bear case
-$4.31
—
No growth
…
—
Base case
$14.17
Price 12% below
Researched bygemini-3.8-flash-medium
Valuation Nov 6, 2026 · Price as of Nov 16, 2026How we got here

What does Chemours do?

Chemours provides refrigerants, titanium dioxide pigments, and fluoropolymer resins to manufacturers in the automotive, electronics, and industrial sectors to enable thermal management and material durability.

It brought in $5.8B of sales in the 12 months to Sep 2026.

Led by Denise M. Dignam, President and Chief Executive Officer since 2024. Chemours Announces Appointment of Denise Dignam as President and Chief Executive Officer of the Company

Industry
Materials
Based in
Wilmington, Delaware
Trades on
NYSE as CC

Here is where each dollar a customer pays ends up. For every $1 of sales in the 12 months to Sep 2026, it spent about $1.03, so it lost 3¢ on each dollar. The biggest cost is making what it sells, 85¢ of every dollar.

$1 of sales
  • Making what it sells85¢
  • Research and development2¢
  • Everything else, including interest11¢
  • Tax5¢
  • Lost on each dollar−3¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays Chemours, and for what?

Chemours makes performance chemicals used in products and industrial processes. It earns revenue by selling refrigerants and cooling products, titanium dioxide white pigment, and high-performance polymers and materials to customers around the world.

Its customers are mainly businesses, including makers of coatings, plastics, vehicles, electronics, cooling systems, and industrial equipment, as well as distributors.

  • Thermal & Specialized Solutions

    36%

    Refrigerants, cooling solutions, propellants, foam-blowing agents, and specialty solvents.

  • Titanium Technologies

    42%

    Titanium dioxide pigment, a white pigment used in coatings, plastics, paper, and other products.

  • Advanced Performance Materials

    22%

    Specialty polymers, membranes, resins, and coatings for electronics, transportation, energy, and industrial uses.

Share of the latest fiscal year's sales, as the company reports it.

Where its work physically happens, beyond headquarters:

  • Washington Works — Washington, United States. This key Advanced Performance Materials facility makes fluoropolymers, including PFA resin used in the domestic semiconductor supply chain.
  • Corpus Christi plant — Ingleside, United States. Its expanded Opteon refrigerant capacity supports sales as customers move to lower global warming potential products.
  • Altamira plant — Altamira, Mexico. This titanium dioxide plant produces multiple pigment grades for markets across Latin America, Europe, and Asia.
  • DeLisle plant — DeLisle, United States. This major titanium dioxide facility supplies pigment used in coatings, plastics, laminates, and paper.
  • New Johnsonville plant — New Johnsonville, United States. The plant produces a wide range of Ti-Pure titanium dioxide grades for coatings and plastics.
See them on the globe

Chemours 2025 Form 10-K

How is the business doing?

Sales grew from $5B in 2020 to $5.8B in 2025, about 3% a year.

After paying for its upkeep and new investment, it had $211M of cash to spare in the 12 months to Sep 2026.

Sales$5.8B
20162025
Free cash flow$51M
20162025
Each bar is one fiscal year (2016–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

Chemours says it aims to deliver trusted chemistry that makes lives better and helps communities thrive.

“To deliver Trusted Chemistry, making lives better and helping communities thrive.”

The Chemours Company Vision

Who is responsible for the plan?

Roles checked November 14, 2026.

What management says it is working on now:

  • Improve operations and lower costs

    Management is working to improve manufacturing reliability, standardize work, and control costs across its businesses.

    Chemours Q2 2026 Earnings Call Transcript
  • Grow in advanced markets

    Management is focusing growth investment on data center cooling, next-generation refrigerants, semiconductors, and other advanced electronics applications.

    Chemours 2025 Form 10-K
  • Shift toward higher-value products

    Management is aiming to increase the portion of the business serving higher-growth, higher-margin applications, including specialty materials for data centers and semiconductors.

    Chemours Q2 2026 Earnings Call Transcript
  • Strengthen the balance sheet

    Management says it is focused on generating cash, reducing debt, and lowering leverage while funding selected growth projects.

    Chemours Q2 2026 Earnings Call Transcript
  • Address legacy environmental and legal matters

    Management is prioritizing resolution of legacy litigation and responsible manufacturing as part of its long-term strategy.

    Chemours 2025 Form 10-K
2026 net sales growth, 2026
1% to 5% over 2025
Chemours Q2 2026 Earnings Call Transcript
2026 Adjusted EBITDA, 2026
$775 million to $825 million
Chemours Q2 2026 Earnings Call Transcript
Net leverage ratio, By the end of 2026
Around 3.8x Adjusted EBITDA
Chemours Q2 2026 Earnings Call Transcript
Net leverage ratio, Longer term
Sustainably below 3x Adjusted EBITDA
Chemours Q2 2026 Earnings Call Transcript
Adjusted EBITDA, In the coming years; no specific year stated
$1 billion
Chemours Q2 2026 Earnings Call Transcript
Free cash flow conversion, 2026 and longer term
Above 25% for 2026; 40% or more longer term
Chemours Q2 2026 Earnings Call Transcript
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is picking up. In Q3 2026 it sold 3% more than a year earlier. The year before, quarters averaged -1%.

Since Oct 2026 the share price has fallen 5%, from $13.19 to $12.48.

Bull $43.73Base $14.17Bear -$4.31Oct 30Nov 16 · $12.48
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 30, 2026.

Recently

Coming up

  • November 3, 2026

    Third-quarter 2026 earnings

    Chemours is scheduled to report results and hold its earnings call, giving an update on demand, pricing, and progress against its outlook.

    Chemours Events & Presentations
  • Expected by mid-2026

    Remaining Kuan Yin land sale closings

    The company expects to complete closings for the remaining Taiwan land parcels and use the proceeds to reduce debt, subject to closing conditions and local approvals.

    Chemours 2025 Form 10-K
  • Around the end of the first quarter of 2027

    Refrigerant aftermarket restocking

    Management expects the refrigerant aftermarket to begin picking up as distributors restock ahead of the next cooling season.

    Chemours Q2 2026 Earnings Call Transcript
  • Ongoing; no launch date stated

    Two-phase liquid cooling customer trials

    Chemours says trials of its liquid cooling products are growing, with customer qualification and sampling expected to shape whether the offering expands in data center use.

    Chemours Q2 2026 Earnings Call Transcript

Our own estimate moved too: the base case went from $7.75 to $14.17 a share between our last two valuations.

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Environmental rules and compliance costs

    Changing rules on emissions and chemicals could require added spending, restrict operations, or change demand for some products.

    From the company's own filingsWould hit how much of each sale it keepsChemours 2025 Form 10-K

  2. Environmental remediation and litigation

    Chemours has significant recorded environmental and legal liabilities, including long-term PFAS-related obligations. Payments and new claims could weigh on cash available for operations and investment.

    From the company's own filingsWould hit how much it has to reinvestChemours 2025 Form 10-K

  3. Cyclical demand and pricing pressure

    Demand for pigment and some specialty materials moves with construction and industrial markets. Weak demand or price competition can reduce sales and margins.

    From the company's own filingsWould hit how fast sales growChemours 2025 Form 10-K

  4. Manufacturing disruptions

    The Washington Works outage reduced production and raised costs. A future interruption at a key site could again limit supply and hurt earnings.

    From the company's own filingsWould hit how much of each sale it keepsChemours 2025 Form 10-K

  5. Raw material and energy costs

    Changes in the cost or availability of ores, chlorine, energy, and other inputs can raise production costs, and the company may not be able to pass all increases on to customers.

    From the company's own filingsWould hit how much of each sale it keepsChemours 2025 Form 10-K

  6. Debt and liquidity

    Chemours has substantial debt and interest costs. If cash generation weakens or financing becomes more expensive, meeting obligations and funding investment could become harder.

    From the company's own filingsWould hit how much it has to reinvestChemours 2025 Form 10-K

  7. Year-to-date net sales of $4,512 million for the first nine months of 2026 rose just 0.8% over the prior year period ($4,478 million).

    From our researchWould hit how fast sales growChemours Q3 2026 Form 10-Q Financial Statements

  8. GAAP operating results in 2025 showed an operating loss of $(64) million due to asset impairment and lower plant utilization.

    From our researchWould hit how much of each sale it keepsChemours 2025 Form 10-K Consolidated Statements of Operations

Is it a good business?

From 2016 to 2025 it earned between -154% and 98% on its shareholders' equity, a median of 20%.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on equity-154%
20162025
Return on invested capital is operating profit after tax (at the median effective rate, 18%) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

The number of shares has held roughly steady over the past year.

It owes $3.1B more than it holds in cash. An operating-profit comparison is unavailable from the published quarters.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $12.48. Our put its value between -$4.31 and $43.73, with $14.17 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, -$4.31

This scenario envisions prolonged weakness in the paint and coating pigment markets alongside ongoing chemical compliance costs, keeping sales essentially flat and profitability modest.

Base case, $14.17

This scenario reflects a steady operational recovery as cost-saving initiatives take hold and demand for eco-friendly refrigerants offsets mature legacy chemical volumes.

Bull case, $43.73

This scenario captures a robust rebound in industrial chemical demand, rapid adoption of clean-energy materials, and improved factory efficiency that restores historical earnings strength.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price and our value are close.Margin of safety: 12%

For Chemours to be worth today's $12.48, sales would need to grow about 1.4% a year. We assume 2.6%. Over the last 5 years, sales shrank 0.9% a year.

−2%−1%0%+1%+2%+3%+4%Past 5 yrs −0.9%Price needs 1.4%We assume 2.6%

Or, if sales grow 2.6% as we assume, the price works with a profit margin of 8.1% (we assume 8.5%).

Keep in mind: a gap this small is normal. A small change in almost any assumption would close it.

Do you think sales can grow 1.4% a year?

Try your own numbers

We're not very sure of this range: it scores 48 out of 100 on our checks. The weakest point is scenario dispersion.

Test the assumptions

Our base value of $14.17 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average2.6%
  • Operating margin8.5%
  • Long-term growth rate2.2%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$14.17 13.5%

Build